Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of IV Tapentadol with and without Oral Charcoal
NCT03951987Phase 1Completed
- Sponsor
- Grünenthal GmbH
- Start
- Feb 2004
- Primary completion
- Apr 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tapentadol in pain (2 arms), sponsored by Grünenthal GmbH. Primary endpoints: Area under the concentration-time curve extrapolated to infinity for CG5503 base in Serum at 23 hours, Area under the concentration-time curve extrapolated to infinity for CG5503 base in Saliva at 23 hours and 3 more. Started Feb 2004; status: completed.
02
Drugs
tapentadol
03
Conditions
pain
Beyond the preview
Go deeper on NCT03951987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03951987.